Summary The expression of the small cell carcinoma (SCLC) antigens cluster-5 (antibody LAM8) and cluster-5A (antibody SWA20) was examined on a panel of routinely processed biopsy or surgical specimens of 290 lung tumours by immunoperoxidase staining. Antigen expression was largely restricted to SCLC. Of over 150 tissue samples evaluated, moderate or strong antigen expression was found in 49% (cluster-5) and 45% (cluster-5A). Concordance in expression of the two antigens was seen in 71% of SCLC samples, with 35% expressing both antigens strongly, 8% moderately and 28% being negative for both antigens. Antigen expression was independent of the morphological subtype of SCLC. (Stahel et al., 1985) , antigens shared with white blood cells (Bunn et al., 1985; Cailland et al., 1984) , neuroendocrine antigens (De Leij et al., 1985; Takahashi et al., 1986; Watanabe et al., 1987 ) and tumour-associated antigens (Waibel et al., 1987; Waibel et al., 1988) . In the past, it has been very difficult to evaluate individual antibodies based on the original reports, since different laboratories varied widely on the material and methods used for the description of antibody and antigens. Since the First International Workshop for Small Cell Lung Cancer Antigens (Souhami et al., 1987) , where antibodies have been analysed comparatively and five clusters of membrane antigens have been identified, the evaluation and reporting of individual antibodies has been greatly facilitated.
Summary The expression of the small cell carcinoma (SCLC) antigens cluster-5 (antibody LAM8) and cluster-5A (antibody SWA20) was examined on a panel of routinely processed biopsy or surgical specimens of 290 lung tumours by immunoperoxidase staining. Antigen expression was largely restricted to SCLC. Of over 150 tissue samples evaluated, moderate or strong antigen expression was found in 49% (cluster-5) and 45% (cluster-5A). Concordance in expression of the two antigens was seen in 71% of SCLC samples, with 35% expressing both antigens strongly, 8% moderately and 28% being negative for both antigens. Antigen expression was independent of the morphological subtype of SCLC. Primary lung tumours of other histology, including squamous cell carcinoma, large cell carcinoma, adenocarcinoma, mesothelioma or carcinoid had no significant antigen expression. Of 135 tumours, strong or moderate expression of both antigens was seen only in two cases. 20%, mostly carcinoids, were weakly positive for cluster 5 and 4% for cluster SA antigen. The remainder were antigen negative. No significant antigen expression was seen in 25 normal lung tissues. The membrane antigens of SCLC cluster 5 and 5A are marker for SCLC and their expression in tissues is tumour-associated.
Small cell lung carcinoma (SCLC) cells express on their surface membrane a number of structures which have little or no expression on lung tumour cells of other lineage or on normal epithelial cells. This was first shown by Baylin by two-dimensional gel electrophoresis (Baylin et al., 1982) and later by us and others using monoclonal antibody techniques. Cell surface antigens on SCLC identified by monoclonal antibodies can be grouped according to reported tissue reactivities into epithelial antigens (Stahel et al., 1985) , antigens shared with white blood cells (Bunn et al., 1985; Cailland et al., 1984) , neuroendocrine antigens (De Leij et al., 1985; Takahashi et al., 1986; Watanabe et al., 1987) and tumour-associated antigens (Waibel et al., 1987; Waibel et al., 1988) . In the past, it has been very difficult to evaluate individual antibodies based on the original reports, since different laboratories varied widely on the material and methods used for the description of antibody and antigens. Since the First International Workshop for Small Cell Lung Cancer Antigens (Souhami et al., 1987) , where antibodies have been analysed comparatively and five clusters of membrane antigens have been identified, the evaluation and reporting of individual antibodies has been greatly facilitated.
We have previously reported on the characteristics of two antibodies, the IgM antibody LAM8 and the IgG2a antibody SWA20, which recognise closely related, but not identical membrane sialoglycoproteins heterogeneously expressed in SCLC (Stahel et al., 1986; Waibel et al., 1987 Waibel et al., , 1988 . By immunoperoxidase technique both antibodies stained equally well frozen and formalin fixed tissues of SCLC, while little or no reactivity was found with non-small cell carcinomas of lung, extrapulmonary carcinomas, and normal tissues, including bronchial epithelium and epithelium of the gastrointestinal tract, liver, kidney, pancreas, lymphoid organs, bone marrow, peripheral nerve and brain. Because of the virtual absence of expression in normal tissues, the antigens were called tumour-associated antigens of SCLC. In the First International Workshop on Small Cell Lung Cancer Antigens, the antibody LAM8 was designated to SCLC cluster-5 (CL-5) and the antibody SWA20 to SCLC cluster-5 associated (CL-5A) (Beverly et al., 1988) .
The aim of this study was to determine whether these two antibodies. could be used in formalin-fixed, paraffinembedded biopsy and surgical tissues obtained in a routine setting, and whether their restrictive reactivity with SCLC could be confirmed when larger numbers of tissues of all types of primary lung tumours were examined. 
Materials and methods

Antibodies
The mouse monoclonal antibodies used for tissues staining have been raised against intact SCLC cells of the cell line SW2. The reactivity of the antibodies with cell lines and a limited number of tissues and the characterisation of their antigens as distinct membrane sialoglycoproteins has been reported (Stahel et al., 1986; Waibel et al., 1987 Waibel et al., , 1988 (Table III) . Concordance between expression of the two antigens was seen in 108 cases (71%). Fifty-four samples (35%) expressed both antigens strongly or moderately, 12 (8%) weakly and 42 (28%) expressed neither antigen. Twelve samples strongly expressed CL-5 antigen, but were negative for CL-5A, and four samples strongly expressed CL-5A antigen, but were negative for CL-5.
The question whether antigen expression might be associated with a histological subtype of SCLC was investigated. SCLC were classified morphologically into oat-cell type and intermediate type according to the WHO classification used at the time of diagnosis (Anonymous, 1982) and examined separately for antigen expression. As seen in Table IV , there was no difference in antigen expression among the morphological subtypes of SCLC.
Sequential tissue samples with immunohistochemical staining were obtained from five patients with SCLC (Table V) .
The tumours of three patients were positive for both antigens on sequential samples. In two patients in whom a tumour diagnosis could not be firmly established histologically on the first biopsy, immunohistochemical positivity also was only seen on the definitive diagnostic specimen.
Discussion
This report on routinely processed lung tissues confirms the restricted expression of the SCLC antigens CL-5 and CL-5A in a proportion of SCLC, and the absence of expression from virtually all lung tumours of other histology. As observed in our initial studies on a limited number of specimens (Stahel et al., 1986; Waibel et al., 1988 ) the antigen expression in SCLC again was found to be heterogeneous. CL-5 and CL-5A antigens were expressed strongly or moderately in 49 and 45% of SCLC, respectively, 30 and 41% were antigen negative and the remainder had weak antigen expression. Heterogeneous expression was seen both in bronchial biopsies as well as in resection specimens. The reason for the heterogeneity of antigen expression has not yet been determined. From the findings presented here, it can be concluded that the antigen expression is not associated with a certain histological subtype of SCLC. However, preliminary evidence from in vitro studies suggests that both antigens are restricted in their expression to the classic type of SCLC cell lines (Reeve et al., 1988; Carney & Stahel, unpublished results) . In addition to SCLC, a large number of other pulmonary and extrapulmonary tumour cell lines and a limited number of pulmonary and extrapulmonary tumour tissues have been previously examined for expression of CL-5 and CL-5A antigens (Stahel et al., 1986; Waibel et al., 1988) . Neither antigen could be demonstrated on cell lines other than SCLC by indirect immunofluorescence staining or radioimmunoassay and antigen expression was weak or mostly absent in other pulmonary and extrapulmonary tumour tissues by immunohistochemical staining. The results presented here show moderate antigen expression in only two of 135 primary lung tumours other than SCLC. Of these one was classified as carcinoid, and in the other the diagnosis was changed from poorly differentiated squamous cell carcinoma in a biopsy to SCLC in the surgical resected tissue. It thus follows that the antigens SCLC CL-5 and CL-5A are highly restricted to SCLC in vitro and in vivo.
The antigens were not expressed in normal bronchial tissues and lung parenchyma. In the current as in our previous studies (Stahel et al., 1986; Waibel et al., 1988) only rare single cells (less than 1 %) in some samples of the bronchial epithelium have been antigen positive. Examination of primary cultures of bronchial epithelial cells confirmed these findings (Bernal et al., 1988) . Antigen positivity could also occasionally be demonstrated in a proportion of bronchial submucosal glands. In these cases it was difficult to determine whether the positivity was associated with cells or mucin. We have previously demonstrated the absence of the antigens from other normal tissues, including blood cells, neural and neuroendocrine tissues, liver, kidney and mesenchymal tissues (Stahel et al., 1986; Waibel et al., 1988) . Thus a differential expression of both antigens between a proportion of SCLC and normal lung tissues (and other normal tissues) has now been clearly established.
The antigens identified by antibody LAM8 and SWA20
were found to be co-expressed on SCLC cell lines (Waibel et al., 1988) . The concordance of the intensity of CL-5 and CL-5A expression on SCLC tissues observed in this study suggests that a co-expression of the two antigens might also exist in vivo. Despite being co-expressed on SCLC cell lines, being sialylated in nature and having similar molecular weights, CL-5 and CL-5A are not identical antigens. Antibodies LAM8 and SWA20 do not compete for antigen binding and antibody SWA20 does not react with immunoabsorbed LAM8 antigen (Waibel et al., 1988) . It could be speculated that SCLC cells expressing the antigens have a common alteration in the activities of enzymes responsible for post-translational sialylation of membrane proteins. Investigation into the biosynthesis of the antigen will help to answer this question. The studies presented here suggest that the antibodies LAM8 and SWA20 might be useful adjuncts in the pathological diagnosis of SCLC, especially since the antigens they recognise are resistant to routine formalin-fixation and paraffin-embedding. However, the fact that only a proportion of small cell tumours strongly express the antigens poses some limitations. On the other hand, strong tissue staining appears to be quite specific for SCLC and thus a positive result would serve as strong support for a lung tumour being a SCLC. The few sequential biopsies on SCLC in our series indicate that heterogeneity in staining might not be a major problem in the diagnostic use of the antibodies.
In addition to diagnostic possibilities, the fact that CL-5 and CL-5A antigens are selectively expressed in a proportion of SCLC in vivo, but not in normal epithelial cells, white blood cells or neuroendocrine cells, warrants investigations into the use of these antigens as targets for radioimaging and immunotherapy.
